Drug repositioning based on the reversal of gene expression signatures identifies top2a as a therapeutic target for rectal cancer

Robson Francisco Carvalho*, Luisa Matos Do Canto, Sarah Santiloni Cury, Torben Frøstrup Hansen, Lars Henrik Jensen, Silvia Regina Rogatto

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Drug repositioning based on the reversal of gene expression signatures identifies top2a as a therapeutic target for rectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences